Valeant Pharmaceuticals International, Inc. says it will buy a major Egyptian pharmaceutical company for about $800 million US as a platform for further expansion in the Middle East and North Africa.
from CBC | Health News http://ift.tt/1CLhEhj
ABOUT THE AUTHOR
Hello We are OddThemes, Our name came from the fact that we are UNIQUE. We specialize in designing premium looking fully customizable highly responsive blogger templates. We at OddThemes do carry a philosophy that: Nothing Is Impossible
0 commentaires:
Enregistrer un commentaire